Jonathan W. Cunningham

Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials

Muthiah Vaduganathan, Brian Claggett, Pardeep S. Jhund et al. · The Lancet · 2020 · 617 citations

Heart Failure, Cardiovascular Disease, Lifetime Benefits +10

Clinical Characteristics and Outcomes of Hospitalized Women Giving Birth With and Without COVID-19

Karola Jering, Brian Claggett, Jonathan W. Cunningham et al. · JAMA Internal Medicine · 2021 · 247 citations · Full text

Clinical Outcomes in Young US Adults Hospitalized With COVID-19

Jonathan W. Cunningham, Muthiah Vaduganathan, Brian Claggett et al. · JAMA Internal Medicine · 2020 · 231 citations · Full text

Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial

Philip M. Bath, Lisa J Woodhouse, Jason P. Appleton et al. · The Lancet · 2017 · 176 citations · Full text

Clinical Outcomes in Patients With Heart Failure Hospitalized With COVID-19

Ankeet S. Bhatt, Karola Jering, Muthiah Vaduganathan et al. · JACC Heart Failure · 2020 · 141 citations · Full text